It's not just Pfizer Inc. that's debating this; all the world's leading pharmaceutical experts have expressed their opinions on this new drug, and a barrage of questions and doubts has emerged.
As stated in the paper, there are two points that are most likely to be criticized.
The first problem is the lack of clinical data, with only a dozen or so cases.
The second issue is that the treatment period was too short, only one month, which only proves its effectiveness in the short term.
This is different from drugs that treat Cancer. Cancer is fatal for many people, and the disease can deteriorate rapidly; a person can die within a few months.
However, Alzheimer's disease is not fatal, and patients can generally live for 8-10 years. If they are well cared for, it is not impossible for them to live for more than 10 or 20 years.
These patients have been taking medication to control their conditions for a long time, and they also have various chronic diseases and are taking other medications.
A drug may not show any problems in the short term, but if taken for one or two years, or even five or six years, the possibility of causing cancer or other fatal diseases will greatly increase.
Therefore, medications that are taken long-term require extensive clinical trials to confirm their safety and side effects.
As for drug resistance caused by long-term use, that's another issue. In short, the standards for long-term drugs and immediate-acting drugs are not the same.
Controversy often brings a surge in online traffic. The Three Purities drug, a highly effective treatment, has already become a sensation even while still in clinical trials, and not just in China, but globally.
More and more patients and their families learned of the news online and in the news, and they were all overjoyed.
Patients in China are anxiously contacting relevant personnel at Three Purities Hospital to inquire where they can participate in subsequent clinical trials.
Patients abroad can only post online, hoping that the effective drug Three Purities can be launched in their countries as soon as possible to benefit patients around the world.
Because compared to Cancer, the pain of forgetting one's family, or even oneself, is far more agonizing.
Moreover, this suffering is not just temporary, but will continue until the end of the patient's life.
What's even more frightening is that caring for an elderly person with Alzheimer's disease is even more troublesome than caring for a paralyzed elderly person.
This means that for at least 5 to 10 years, not only will the patient suffer, but the pain inflicted on their family will be endless, even a double torment of mind and body.
After seeing the online debate among experts, patients voiced their support, saying they were willing to try anything that could help Alzheimer's disease's patients regain their memories and stay lucid, even if there were other side effects.
Furthermore, netizens have begun to have heated discussions online about whether life or memory is more important to humankind.
"Would you choose to live a life incomplete or to die a complete death?"
"I choose to remember. Even if you get poisoned or develop Cancer after taking this medicine, there are ways to deal with them. At the very least, you can live like a human being and die with the dignity of an apex primate."
"Me too. At least you know who you are, recognize your family, you can call out your son and wife's names again, and you can even walk out of your house, look at your neighbor and say, 'Hey, old idiot George, remember me? I'm back.' Is there anything better than that? Even if I died right afterward, I would feel it was worth it."
"I want to ask these experts, have you ever had a family member with Alzheimer's disease? Do you understand the pain that such a patient brings to their family? If not, then shut your mouths and give us truly effective drugs instead of just whining and spouting nonsense."
"Those who haven't experienced it will never know what it's like. My father was diagnosed with this disease three years ago. Losing his memory wasn't the most painful thing; the most painful thing was losing his dignity as a human being. With this disease, you become like an animal, losing all your understanding of the world. One day, I came home and saw my father, who used to be a university professor, put his hand into the toilet, splashing water while looking at it curiously. From that moment on, I knew I had completely lost him."
"My family has a history of Alzheimer's disease. This disease is a nightmare for me, and a nightmare from which I can never wake up. I watched my grandmother and mother fall ill one after another. My mother took care of my grandmother her whole life. After discovering that she had the disease, she resolutely committed suicide by shooting herself. In her last words, she said that she could not accept being a burden on me for the rest of her life. As for me, I have already decided to spend the rest of my life alone. When I fall ill, I will also swallow a bottle of Sleeping Pill. I will never bring this pain to anyone again."
"Poor Amy0021, God bless you!"
The online debate intensified, and ultimately the patients' voices overwhelmingly prevailed.
After all, no one likes to live a muddled, zombie-like existence, forgetting family and friends, forgetting the past, forgetting everything.
Three Purities is actually happy to see the controversy online. After all, the longer the debate lasts and the more people participate, the more people will believe in the efficacy of the drug and be willing to accept its treatment after it is launched on the market.
However, in order to take care of the patients who came to them, Three Purities contacted well-known Grade A Tertiary Hospitals in Sea City and Capital City to conduct Phase II clinical trial.
In order to obtain more case data and quell the controversy as soon as possible, the number of participants in each location has been increased to 500. After the second phase, a third phase of clinical trials will be carried out, at which time the number of participants will increase to more than 1,000.
In short, once the Phase II of these 1,500 people is completed and we have real and effective treatment data, any controversy can be quelled.
Because they cured Old Man Xie's illness and allowed him to return to his post, both Academicians Old Man Xie and Old Man Qi strongly recommended him to their superiors.
Therefore, as a domestically produced innovative drug that fills the current treatment gap in this field and has made groundbreaking achievements, Three Purities, a highly effective drug, has been granted a green channel.
After the completion of Phase II clinical trials, Phase III clinical trials will be launched as quickly as possible, and the market approval process will also be simplified.
The goal is to treat more patients as quickly as possible, help them recover soon, and enable them to return to their families like normal people.
Just then, amidst global discussion, Fox News, a news outlet in the Eagle Country, published a groundbreaking report.
"Is it an original creation or a theft? — On the origins and development of the Three Purities Alzheimer's disease special effect drug!"
"The recently popular Three Purities special effect drug is not an original new drug, but rather a product that stole Pfizer's technology and patents."
"As we all know, Pfizer Inc. announced four years ago that it was abandoning the research and development of neurodegenerative diseases Alzheimer's disease's. The project was stopped, the experts were dismissed, and the patents and technologies were shelved. At that time, there was a China expert who left and immediately returned to China. No one knows why he was in such a hurry back then, or whether there was another reason behind it."
"This China chemist is named Chen Yiqing. He obtained his doctorate from Harvard and could have stayed in the Eagle Country pharmaceutical company with a bright future. However, he ran away and returned to China immediately after the project was stopped. Four years later, he joined Three Purities and within a few months, he successfully developed a new drug in the same research direction that Pfizer had originally been working on. Is this a coincidence or an inevitability?"
"We interviewed several of Chen's former colleagues, all of whom have left the company to join other pharmaceutical companies. They all said that Chen worked very hard and was very proactive in learning related technologies. He was even interested in many unrelated technologies. Such a studious and ambitious person refused a promotion offer after the project was dissolved and resolutely returned to China. This attitude is very thought-provoking and the whole thing is also very thought-provoking."
"In fact, they all said that the research at Pfizer was on the verge of a breakthrough, but it was stopped by the board of directors. This is very regrettable. They have no doubt that Chen will be able to develop a special drug based on this, and they congratulate him."
"Next, please watch our reporter's special interview with relevant individuals..."
This news report was like setting off a bomb, instantly pushing the Three Purities special medicine into the spotlight.